Adial granted U.S. patent for treatment of alcohol, drug dependence
Adial Pharmaceuticals (ADIL) announced patent number 12150931 was issued on November 26, 2024 by the United States Patent and Trademark Office, ...
manilatimes1d
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the "Company”), a clinical-stage biopharmaceutical company focused on ...
manilatimes1d
Qlik Introduces Enhanced Integrations with SAP, Databricks, and Snowflake to Drive Greater AI Value Creation
Qlik's expanded capabilities strengthen connectivity across SAP, Databricks, and Snowflake, supporting businesses in ...
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) announced that patent number 12150931 was issued by the United States Patent and ...